Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Por um escritor misterioso
Descrição
The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.
Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures - ScienceDirect
Phenotyping of Methicillin-Resistant Staphylococcus aureus Using a Ratiometric Sensor Array
Investigational agents for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: progress in clinical trials: Expert Opinion on Investigational Drugs: Vol 31, No 3
Pseudomonas aeruginosa and Staphylococcus aureus virulence factors as biomarkers of infection
Reducing the risk of bacteremia
Platelet P2Y12 signalling pathway in the dysregulated immune response during sepsis - Amoafo - British Journal of Pharmacology - Wiley Online Library
Severe community-acquired pneumonia
Estimation of Activity of CD14 Biomarker in Iraqi Burn Patients
Antibiotics, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
